欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/1230/001
药品名称Qlaira Filmtabletten
活性成分
    • dienogest 3.0 mg
    • estradiol valerate 3.0 mg
剂型Film-coated tablet
上市许可持有人Bayer B.V. Energieweg 1 3641 RT Mijdrecht The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Qlaira
互认成员国 - 产品名称
    • Finland (FI)
    • Greece (GR)
    • Portugal (PT)
      Qlaira
    • Spain (ES)
    • France (FR)
    • Ireland (IE)
    • United Kingdom (Northern Ireland) (XI)
    • Iceland (IS)
      Qlaira Filmuhúðuð tafla
    • Luxembourg (LU)
    • Belgium (BE)
    • Denmark (DK)
      Qlaira
    • Germany (DE)
      Qlaira
    • Croatia (HR)
    • Slovenia (SI)
    • Slovakia (SK)
      Qlaira
    • Romania (RO)
      QLAIRA, comprimate filmate
    • Czechia (CZ)
      Qlaira
    • Cyprus (CY)
      QLAIRA
    • Hungary (HU)
      QLAIRA filmtabletta
    • Estonia (EE)
      QLAIRA
    • Latvia (LV)
      Qlaira apvalkotās tabletes
    • Poland (PL)
      Qlaira
    • Norway (NO)
    • Sweden (SE)
      Qlaira
    • Lithuania (LT)
      Qlaira plėvele dengtos tabletės
    • Italy (IT)
    • Austria (AT)
      Qlaira Filmtabletten
    • Malta (MT)
      Qlaira Coated Tablets
许可日期2008/10/14
最近更新日期2023/12/15
药物ATC编码
    • G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase